- Home
- FTRK vs NKTR Comparison
FTRK vs NKTR Comparison
Compare FTRK & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTRK
- NKTR
- Stock Information
- Founded
- FTRK 2012
- NKTR 1990
- Country
- FTRK Singapore
- NKTR United States
- Employees
- FTRK N/A
- NKTR N/A
- Industry
- FTRK
- NKTR Biotechnology: Pharmaceutical Preparations
- Sector
- FTRK
- NKTR Health Care
- Exchange
- FTRK NYSE
- NKTR Nasdaq
- Market Cap
- FTRK 134.1M
- NKTR 108.3M
- IPO Year
- FTRK 2025
- NKTR 1994
- Fundamental
- Price
- FTRK $0.62
- NKTR $25.00
- Analyst Decision
- FTRK
- NKTR Strong Buy
- Analyst Count
- FTRK 0
- NKTR 6
- Target Price
- FTRK N/A
- NKTR $81.67
- AVG Volume (30 Days)
- FTRK 1.6M
- NKTR 1.5M
- Earning Date
- FTRK 01-01-0001
- NKTR 08-07-2025
- Dividend Yield
- FTRK N/A
- NKTR N/A
- EPS Growth
- FTRK N/A
- NKTR N/A
- EPS
- FTRK N/A
- NKTR N/A
- Revenue
- FTRK $751,195.00
- NKTR $87,248,000.00
- Revenue This Year
- FTRK N/A
- NKTR N/A
- Revenue Next Year
- FTRK N/A
- NKTR N/A
- P/E Ratio
- FTRK N/A
- NKTR N/A
- Revenue Growth
- FTRK N/A
- NKTR N/A
- 52 Week Low
- FTRK $0.53
- NKTR $6.48
- 52 Week High
- FTRK $9.69
- NKTR $37.38
- Technical
- Relative Strength Index (RSI)
- FTRK N/A
- NKTR 60.49
- Support Level
- FTRK N/A
- NKTR $23.56
- Resistance Level
- FTRK N/A
- NKTR $26.35
- Average True Range (ATR)
- FTRK 0.00
- NKTR 2.02
- MACD
- FTRK 0.00
- NKTR -0.50
- Stochastic Oscillator
- FTRK 0.00
- NKTR 53.50
About FTRK FAST TRACK GROUP
Fast Track Group is a regional entertainment-focused event management and marketing company that provides a full range of services including experiential marketing, artiste endorsement and management, movie premiere organizations, grand openings, and concerts. It also creates, develops, organizes, hosts, and manages various events and concerts.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.